CoChat

Hypoglycemia: From the Laboratory to the Clinic

Open access
Amiel, Stephanie A. · 2009 · Diabetes Care
Cited by 44

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Hypoglycemia is the major, and most feared, complication of the pharmacological therapies for diabetes. In health, hypoglycemia sufficient to cause clinically relevant impairment of cognitive function or cardiac rhythm is prevented by highly efficient counterregulatory mechanisms that culminate in restoration of circulating glucose concentrations. In the accompanying article, McCrimmon (1) has summarized our current understanding of how these mechanisms may be initiated and coordinated by central glucose sensing, described the possible molecular mechanisms of neuronal glucose sensing, and alluded to the defective performance of these mechanisms in insulin-treated diabetes. The principle clinical correlate of defective brain glucose sensing in diabetes is the change in the patient's awareness of the plasma glucose concentration. The clinical phenomenon of loss of awareness of hypoglycemia, and its associated increase in risk of severe hypoglycemia, is accompanied by measurable defects in the counterregulatory stress responses attributed at least in part to failure of central glucose sensing. As McCrimmon explains, the main determinant of the plasma glucose concentrations at which the brain responds actively to hypoglycemia appears to be the recent antecedent glucose exposure. Thus, people accustomed to chronic hyperglycemia may activate symptomatic stress responses as the glucose concentration falls within the physiological range—a barrier for some to tighten glucose control effectively. More extensively explored is the phenomenon of hypoglycemia unawareness, in which the body only mounts a protective counterregulatory response to falling blood glucose at glucose concentrations well below the physiologic norm. Added to the failure of glucagon responses to hypoglycemia that occurs early in type 1 diabetes, such additional counterregulatory failure may leave the patient symptom free and defenseless until plasma glucose concentrations are insufficient to support normal higher brain function. Confusion becomes the first sign of the hypoglycemia, and severe episodes (those in which the person is rendered incapable of self-treatment) ensue. In …

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc09-0113

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

Metadata

Authors
Amiel, S. A.
Venue
Diabetes Care
Published
2009-08-01
Volume
32
Issue
8
Pages
1364-1371
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2128502852
Cited by
44
References
23
FWCI
2.83
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.